According to Zhitong Finance App News, the US and China Jiahe (02453.HK) issued an announcement. According to the terms and conditions of the loan agreement with Zhongcheng previously signed by the company on July 10, 2024, and to further guarantee the company's responsibilities under the loan agreement, on October 14, 2024, Shanghai Medical Star agreed to use Zhongcheng as the beneficiary to pledge an additional 64.1 million domestic shares (additional pledge shares) of the company (additional pledged shares) (accounting for about 33.34% of the total number of shares directly held by Shanghai Medical Star). As of the date of this announcement, the company's domestic shares (including pledged shares and additional pledged shares) pledged by Shanghai Medical Star accounted for about 12.17% of the total number of issued shares of the company.

According to Zhitong Finance App News, the US and China Jiahe (02453.HK) issued an announcement. According to the terms and conditions of the loan agreement with Zhongcheng previously signed by the company on July 10, 2024, and to further guarantee the company's responsibilities under the loan agreement, on October 14, 2024, Shanghai Medical Star agreed to use Zhongcheng as the beneficiary to pledge an additional 64.1 million domestic shares (additional pledge shares) of the company (additional pledged shares) (accounting for about 33.34% of the total number of shares directly held by Shanghai Medical Star). As of the date of this announcement, the company's domestic shares (including pledged shares and additional pledged shares) pledged by Shanghai Medical Star accounted for about 12.17% of the total number of issued shares of the company.